Shenzhen Weiguang Biological Products Co., Ltd
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Shenzhen Weiguang Biological Products Co., Ltd. (stock code: 002880) is a national high-tech enterprise, the only blood product production enterprise in Shenzhen, and a state-owned listed enterprise in Guangming District. The company was founded in 1985 and is mainly engaged in the research and development, production, and sales of blood products. The products include 9 varieties and 21 specifications, including human blood albumin and intravenous immunoglobulin. The company has won multiple honors, including "Guangdong Province Independent Innovation Demonstration Enterprise", "Shenzhen Science and Technology Innovation Award", "Shenzhen Top 100 Quality Enterprises", and "Shenzhen Top 100 Brands". After nearly 40 years of development, the company has developed into a leading enterprise in blood products with high comprehensive utilization rate of plasma, complete product variety, and strong research and development strength in China. The company covers an area of over 50000 square meters and is building a first-class life science professional park in the science and education core area of Guangming Science City; We have a highly skilled talent team with a total of over 700 employees; A blood preparation workshop with an investment of 350 million yuan and an annual processing capacity of 500 tons of plasma; Having 8 single plasma collection stations and 3 subsidiaries; We have research and development platforms such as the "Guangdong Province Protein (Peptide) Separation and Purification Engineering Technology Research and Development Center", and our research products involve multiple fields such as blood products, vaccines, and recombinant proteins. In the future, the company will comply with the requirements of modern enterprise development, focus on strengthening its main business of blood products, rely on the Weiguang Life Science Park and listing platform, and strive to develop into a pioneer in differentiated blood products in China and a global platform based biopharmaceutical pioneer. |
| Headquarter | Shenzhen |
| Establish Date | 4/7/1986 |
| Listed Code | 002880.SZ |
| Listed Date | 6/16/2017 |
| Chairman | Zhang Zhan. |
| CEO | Guo Caiping. |
| Website | www.szwg.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
